Neumora Therapeutics target price cut to $3 from $4
NMRA•Mizuho cut its target price for Neumora Therapeutics to $3 from $4.
Related News
First Mid Bancshares Q3 profit tops estimates on deposit growth
FMBH•
Veeva showcases AI innovations at Commercial Summit
VEEV•
MGM Resorts International: Stifel cuts target price to $35 from $40
MGM•
DoorDash strikes $17 billion deal for US rival Instacart in grocery delivery push
DASH•
Tenable Holdings target price raised to $45 from $35
TENB•